Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fortress Biotech (FBIO) Return on Equity (2016 - 2025)

Fortress Biotech (FBIO) has 13 years of Return on Equity data on record, last reported at 1.7% in Q3 2025.

  • For Q3 2025, Return on Equity fell 1037.0% year-over-year to 1.7%; the TTM value through Sep 2025 reached 1.7%, down 1037.0%, while the annual FY2024 figure was 4240.11%, 424608.0% up from the prior year.
  • Return on Equity reached 1.7% in Q3 2025 per FBIO's latest filing, up from 3.09% in the prior quarter.
  • Across five years, Return on Equity topped out at 106.41% in Q1 2024 and bottomed at 111.33% in Q2 2023.
  • Average Return on Equity over 5 years is 2.18%, with a median of 0.84% recorded in 2021.
  • Peak YoY movement for Return on Equity: skyrocketed 12240bps in 2024, then crashed -11284bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 0.84% in 2021, then plummeted by -222bps to 2.72% in 2022, then skyrocketed by 1029bps to 25.23% in 2023, then crashed by -38bps to 15.73% in 2024, then plummeted by -111bps to 1.7% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 1.7% in Q3 2025, 3.09% in Q2 2025, and 6.43% in Q1 2025.